TAVR Medical Device Manufacturing

The contract encompasses the full manufacturing, assembly, sterilization, and quality assurance of the PROS V23 618 Transcatheter Aortic Valve Replacement device, covering every stage of production from raw material processing to final product release. All activities must adhere to stringent regulatory and quality standards to ensure patient safety and device performance, with strict compliance required for medical device manufacturing protocols including ISO 13485 and FDA regulations. The scope includes end-to-end control of the production lifecycle, with documented processes for validation, testing, and traceability across all batches. This is a subcontract under the Department of Veterans Affairs, managed by the Network Contract Office 23, with a NAICS code of 339113 indicating medical equipment and supplies manufacturing. The solicitation was posted on May 15, 2026, and performance location details are not specified, implying flexibility in facility placement as long as regulatory and logistical requirements are met. The contractor must maintain rigorous quality systems to support consistent output for a critical implantable medical device, with accountability for sterility, biocompatibility, and functional reliability throughout the supply chain.